LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Entrada Therapeutics (NASDAQ: TRDA)

Follow NASDAQ:TRDA Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
07/09/2025
Sell
$7.50
20,065
$151K
3.16M
NASDAQ TRDA Entrada Therapeutics
PARMAR KUSH / director, 10 percent owner:
07/09/2025
Sell
$7.50
6,935
$52K
1.09M
NASDAQ TRDA Entrada Therapeutics
5AM Ventures V, L.P. / 10 percent owner
07/09/2025
Sell
$7.50
20,065
$151K
3.16M
NASDAQ TRDA Entrada Therapeutics
5AM Ventures V, L.P. / 10 percent owner
07/09/2025
Sell
$7.50
6,935
$52K
1.09M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous